13.05.2024  11:58:59 Изменение +0.95 Объем сделки Бид12:01:10 Предложение12:01:10 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
75.50CHF +1.27% 18,518
Оборот: 1.39 млн
75.25Величина цены спроса: 217 75.65Величина цены предложения: 404 1.18 млрдCHF - 12.26

Описание деятельности

Operating under the "Zur Rose" and "DocMorris" brands, the Swiss-based Zur Rose Group is one of Europe's leading online pharmacy and one of Switzerland's foremost wholesale suppliers to medical practitioners. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management in order to increase therapy safety. The creation of added value and a pronounced patient orientation make the Group an important strategic partner for service providers, cost units and industry. The Zur Rose Group serves the Swiss market from Frauenfeld, Switzerland. In Germany and Austria, the Group operates through subsidiaries in Heerlen (Netherlands) and Halle an der Saale (Germany). Furthermore, it holds a majority interest in BlueCare in Winterthur, one of the leading providers of networking systems in the Swiss healthcare market.
 

Правление & Наблюдательный совет

Исполнительный директор
Walter Hess
Правление
Marcel Ziwica, David Masó, Madhu Nutakki, Matthias Peuckert, Kaspar Niklaus
Наблюдательный совет
Dr. Christian Mielsch, Florian Seubert, Prof. Dr. Andréa Belliger, Prof. Dr. Volker Amelung, Prof. Stefan Feuerstein, Walter Oberhänsli
 

Данные компании

Имя: Zur Rose Group AG
Адрес: Walzmühlestrasse 60,CH-8500 Frauenfeld
Телефон: +41-52-7240020
Факс: +41-52-7240015
E-mail: info@zurrose.com
Интернет: www.zurrosegroup.com
Индустрия: Consumer Goods
Сектор: Retailers
Подсектор: -
Конец финансового года: 31.12
Акции в свободном обращении: 75.60%
Дата IPO: 06.07.2017

Связи с инвесторами

Имя: Marcel Ziwica
IR телефон: +41-52-7240064
IR-факс: -
IR e-mail: marcel.ziwica@zurrose.com

Календарь компании

CW 34 | 20.08.2024 Interim Report 2nd Quarter/6 Months
CW 42 | 15.10.2024 Interim Report 3rd Quarter/9 Months
 

Основные акционеры

Другие
 
85.37%
Frank M. Sands
 
4.93%
Patrick Schmitz-Morkramer Patrick Bierbaum
 
3.79%
Benjamin Leslie Levine
 
3.02%
BlackRock, Inc
 
2.89%